[HTML][HTML] Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer
AS Wong, R Soong, SBK Seah, SW Lim… - Journal of Thoracic …, 2008 - Elsevier
Introduction The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs)
gefitinib and erlotinib are gaining an increasing role in the management of advanced non …
gefitinib and erlotinib are gaining an increasing role in the management of advanced non …
Evidence for Disease Control with Erlotinib after Gefitinib Failure in Typical Gefitinib-Sensitive Asian Patients with Non-small Cell Lung Cancer
AS Wong, R Soong, SBK Seah, SW Lim… - Journal of Thoracic …, 2008 - jto.org
Introduction The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs)
gefitinib and erlotinib are gaining an increasing role in the management of advanced non …
gefitinib and erlotinib are gaining an increasing role in the management of advanced non …
[引用][C] Evidence of disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer
W AS - J Thorac Oncol, 2008 - cir.nii.ac.jp
Evidence of disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive
Asian patients with non-small cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術 …
Asian patients with non-small cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術 …
Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer
AS Wong, R Soong, SBK Seah, SW Lim, KL Chuah… - 2008 - scholarbank.nus.edu.sg
INTRODUCTION: The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
(TKIs) gefitinib and erlotinib are gaining an increasing role in the management of advanced …
(TKIs) gefitinib and erlotinib are gaining an increasing role in the management of advanced …
[PDF][PDF] Evidence for Disease Control with Erlotinib after Gefitinib Failure in Typical Gefitinib-Sensitive Asian Patients with Non-small Cell Lung Cancer
AS Wong, R Soong, SBK Seah, SW Lim… - Journal of Thoracic …, 2008 - core.ac.uk
Results: Fourteen patients were included in the analysis, all of whom received erlotinib after
progression on gefitinib. Chinese race, females, never-smokers, and adenocarcinoma …
progression on gefitinib. Chinese race, females, never-smokers, and adenocarcinoma …
Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer
AS Wong, R Soong, SBK Seah… - Journal of thoracic …, 2008 - pubmed.ncbi.nlm.nih.gov
Introduction The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs)
gefitinib and erlotinib are gaining an increasing role in the management of advanced non …
gefitinib and erlotinib are gaining an increasing role in the management of advanced non …
Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer.
AS Wong, R Soong, SB Seah, SW Lim… - Journal of Thoracic …, 2008 - europepmc.org
Methods We did a retrospective analysis of patients receiving both gefitinib and erlotinib in
our institution during a 2-year period. Patients were to have received the second TKI after …
our institution during a 2-year period. Patients were to have received the second TKI after …
[引用][C] Evidence for Disease Control with Erlotinib after Gefitinib Failure in Typical Gefitinib-Sensitive Asian Patients with Non-small Cell Lung Cancer
AS Wong, R Soong, SBK Seah, SW Lim… - Journal of Thoracic …, 2008 - cir.nii.ac.jp
Evidence for Disease Control with Erlotinib after Gefitinib Failure in Typical Gefitinib-Sensitive
Asian Patients with Non-small Cell Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術 …
Asian Patients with Non-small Cell Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術 …